We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Ascentage Pharma

News List

Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Trial of APG-1387 in Combination with Chemotherapy for the Treatment of Advanced Pancreatic Cancer in China prnasia
February 25, 2020
Ascentage Pharma (6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases.
Ascentage Pharma collaborates with Junshi Bioscience for cancer therapy biospectrumasia
April 10, 2019
Junshi Biosciences' self-developed toripalimab is the first anti-PD-1 monoclonal antibody marketed by a Chinese ^
Ascentage Pharma Announces New License with Unity Biotechnology pharmafocusasia
January 10, 2019
Ascentage Pharma, a global clinical-stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies for cancers and other diseases....
Ascentage Pharma and MD Anderson Cancer Center Announce Strategic Alliance in Cancer Drug Development pharmafocusasia
January 09, 2019
Ascentage Pharma Group, Inc., and The University of Texas MD Anderson Cancer Center today announced a five-year strategic collaboration agreement to advance the development of five potential new cancer therapies.....

Previous page 1 2 Next page